Skip to content

Geron GERN EBITDA margin

EBITDA margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
27.2%-2.2pp
Incyte logo
IncyteINCY
31.8%+25.8pp
Immunome logo
ImmunomeIMNM
-5,886.7%-11,897pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-164.8%-51.5pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-202.5%-60.0pp
Exelixis logo
ExelixisEXEL
40.6%+6.2pp

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-8.6%
Enterprise value$973.78M-6.2%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Calculated from Geron’s reported figures.

Based on trailing twelve months.

The official record: Geron’s 10-Q, filed November 7, 2024, on SEC EDGAR. View the filing →

Ask your AI about Geron's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's EBITDA margin?
Geron (GERN) reported EBITDA margin of -703.7% in Q3 2024.
How has Geron's EBITDA margin changed year-over-year?
Geron's EBITDA margin increased by 98.8% year-over-year, from -57,160.3% to -703.7%.
What is the long-term trend for Geron's EBITDA margin?
Over 3 years (2020 to 2023), Geron's EBITDA margin has grown at a 39.1% compound annual growth rate (CAGR), from -30,337.9% to -81,646.4%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.